Back to Trials
NCT07141407NARecruitingAccepts Healthy Volunteers

Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person

Fred Hutchinson Cancer Center

Start Date

4/8/2026

Completion Date

12/14/2026

Summary

This clinical trial studies whether telephone-based coaching sessions, Talking About Cancer (TAC), work to improve engagement in advance care planning (ACP) in patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) and their support person. Participation in ACP, which includes having end of life (EOL) care conversations and completing advance directives (e.g., living will, health care proxy, do not resuscitate order), improves quality EOL care. Despite this, less than half of patients with advanced cancer have EOL care conversations or complete advance directives. TAC coaching sessions are delivered by a social worker over the phone. They are designed to help patients and their support person communicate about ACP, manage the distress these conversations can cause, and participate in the process of ACP with a clear action plan of having goals-of-care conversations and completing advance directives. This may be an effective way to improve ACP participation in advanced cancer patients and their support person.

Detailed Description

OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants attend Talking About Cancer (TAC) telephone-based coaching sessions (2 sessions) designed to support participants in communicating about advance care planning (ACP), managing distress around ACP conversations, engaging in the process of ACP, and completing advance directives over 45-60 minutes each once a week (QW) for 2 weeks. ARM II: Participants receive an ACP brochure/handout on study. After completion of study intervention, participants are followed up at 6- and 12-weeks post-randomization.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * PATIENT: Current diagnosis of stage III or IV cancer * PATIENT: Able to provide informed consent * PATIENT: Fluent in English or Spanish * PATIENT: Have access to a telephone, computer, or mobile device * CAREGIVER (SUPPORT PERSON): Person patient indicates provides support * CAREGIVER (SUPPORT PERSON): English or Spanish speaking * CAREGIVER (SUPPORT PERSON): 18 years of age or older * CAREGIVER (SUPPORT PERSON): Able to provide informed consent Exclusion Criteria: * PATIENT: Too ill or weak to complete the interviews (as judged by the interviewer) * PATIENT: Receiving hospice at the time of enrollment * PATIENT: Younger than age 18

Interventions

OTHER

Supportive Care

BEHAVIORAL

Telephone-Based Intervention

OTHER

Survey Administration

OTHER

Educational Intervention

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Advanced Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm

Locations

Providence Regional Cancer Partnership

Everett, Washington 98201

United States

Skagit Regional Health Cancer Care Center

Mount Vernon, Washington 98274

United States

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington 98109

United States